Matches in Wikidata for { <http://www.wikidata.org/entity/Q80871430> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q80871430 description "artículu científicu espublizáu en xunetu de 2008" @default.
- Q80871430 description "im Juli 2008 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80871430 description "scientific article published on 01 July 2008" @default.
- Q80871430 description "wetenschappelijk artikel" @default.
- Q80871430 description "наукова стаття, опублікована в липні 2008" @default.
- Q80871430 name "Post-marketing safety of antineoplasic monoclonal antibodies: rituximab and trastuzumab" @default.
- Q80871430 name "Post-marketing safety of antineoplasic monoclonal antibodies: rituximab and trastuzumab" @default.
- Q80871430 type Item @default.
- Q80871430 label "Post-marketing safety of antineoplasic monoclonal antibodies: rituximab and trastuzumab" @default.
- Q80871430 label "Post-marketing safety of antineoplasic monoclonal antibodies: rituximab and trastuzumab" @default.
- Q80871430 prefLabel "Post-marketing safety of antineoplasic monoclonal antibodies: rituximab and trastuzumab" @default.
- Q80871430 prefLabel "Post-marketing safety of antineoplasic monoclonal antibodies: rituximab and trastuzumab" @default.
- Q80871430 P1104 Q80871430-F036593C-AE2C-4A4B-B1EE-7FC56D3BE086 @default.
- Q80871430 P1433 Q80871430-FF8F6F14-B452-4897-A9CD-465D3A26C7D5 @default.
- Q80871430 P1476 Q80871430-936ACA88-7CD9-4F34-9236-CB533691462E @default.
- Q80871430 P2093 Q80871430-052E7916-20DE-477A-9634-28172C73F4B0 @default.
- Q80871430 P2093 Q80871430-20B14081-3F68-4EC5-AE34-AFFE48C2990C @default.
- Q80871430 P2093 Q80871430-81352359-588E-41E5-AB84-D0E40029C50E @default.
- Q80871430 P2093 Q80871430-840181CD-A5B4-41BE-9685-8918E86E04F9 @default.
- Q80871430 P2093 Q80871430-EAADAB41-863A-407E-BD67-CA117593503C @default.
- Q80871430 P304 Q80871430-DF765984-4441-48A6-879A-F82758DD4796 @default.
- Q80871430 P31 Q80871430-1EB73349-8032-4B66-ABFD-FA73A163C83F @default.
- Q80871430 P356 Q80871430-1424240D-5435-4A03-BA23-A2075DD11C3C @default.
- Q80871430 P433 Q80871430-C15053B2-5976-4F33-BB02-73429D1628E3 @default.
- Q80871430 P478 Q80871430-3CD79A20-033C-46BC-938A-9C8DA61E1E6B @default.
- Q80871430 P50 Q80871430-B37C8F4F-5DD2-436D-A108-2E0A6BD21D68 @default.
- Q80871430 P577 Q80871430-21E16F3A-029E-4583-943A-822433E7D4E2 @default.
- Q80871430 P698 Q80871430-DF9E7056-1DAB-4D3A-9AD6-BEB6B37192A6 @default.
- Q80871430 P921 Q80871430-B3BB00F1-6786-4FAA-A8F3-FA2E4485570A @default.
- Q80871430 P921 Q80871430-F3FAF727-7835-4009-9B58-4D10678D1333 @default.
- Q80871430 P921 Q80871430-FEB8C8C3-B2B1-4C7C-96DF-11D75D923575 @default.
- Q80871430 P356 PDS.1587 @default.
- Q80871430 P698 18340626 @default.
- Q80871430 P1104 "+8" @default.
- Q80871430 P1433 Q15759496 @default.
- Q80871430 P1476 "Post-marketing safety of antineoplasic monoclonal antibodies: rituximab and trastuzumab" @default.
- Q80871430 P2093 "A Hidalgo" @default.
- Q80871430 P2093 "F J Jimeno" @default.
- Q80871430 P2093 "G Manso" @default.
- Q80871430 P2093 "T Rubio" @default.
- Q80871430 P2093 "V González" @default.
- Q80871430 P304 "714-721" @default.
- Q80871430 P31 Q13442814 @default.
- Q80871430 P356 "10.1002/PDS.1587" @default.
- Q80871430 P433 "7" @default.
- Q80871430 P478 "17" @default.
- Q80871430 P50 Q73724915 @default.
- Q80871430 P577 "2008-07-01T00:00:00Z" @default.
- Q80871430 P698 "18340626" @default.
- Q80871430 P921 Q412323 @default.
- Q80871430 P921 Q412616 @default.
- Q80871430 P921 Q422248 @default.